These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2641004)

  • 1. Time course of repeated naloxone challenge after single morphine doses in humans.
    Heishman SJ; Stitzer ML
    NIDA Res Monogr; 1989; 95():385-6. PubMed ID: 2641004
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute opioid physical dependence in humans: maximum morphine-naloxone interval.
    Kirby KC; Stitzer ML; Heishman SJ
    NIDA Res Monogr; 1989; 95():393-4. PubMed ID: 2641007
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute physical dependence: time course and relation to human plasma morphine concentrations.
    June HL; Stitzer ML; Cone E
    Clin Pharmacol Ther; 1995 Mar; 57(3):270-80. PubMed ID: 7697945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
    Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1989 Aug; 250(2):485-91. PubMed ID: 2760839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
    Pinelli A; Cighetti G; Trivulzio S
    Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method of reducing the opioid withdrawal intensity using progressively increasing doses of naloxone.
    Langerman L; Steingart RA; Margolis A; Yanai J
    J Pharmacol Toxicol Methods; 1999 Nov; 42(3):115-9. PubMed ID: 10964008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute physical dependence in man: repeated naloxone-precipitated withdrawal after a single dose of methadone.
    Wright C; Bigelow GE; Stitzer ML
    NIDA Res Monogr; 1989; 95():395-6. PubMed ID: 2701308
    [No Abstract]   [Full Text] [Related]  

  • 8. Morphine-induced supersensitivity to the effects of naloxone on luteinizing hormone secretion in the male rat.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Apr; 225(1):35-41. PubMed ID: 6682144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade.
    Hamdy MM; Noda Y; Miyazaki M; Mamiya T; Nozaki A; Nitta A; Sayed M; Assi AA; Gomaa A; Nabeshima T
    Behav Brain Res; 2004 Jul; 152(2):263-70. PubMed ID: 15196794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An experimental study of urodynamic effects of epidural morphine and of naloxone reversal.
    Rawal N; Möllefors K; Axelsson K; Lingårdh G; Widman B
    Anesth Analg; 1983 Jul; 62(7):641-7. PubMed ID: 6859567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute physical dependence in man: effects of naloxone after brief morphine exposure.
    Bickel WK; Stitzer ML; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):126-32. PubMed ID: 3335995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxone-precipitated morphine withdrawal in rats.
    Kimura M; Tokumura M; Itoh T; Inoue O; Abe K
    Neurosci Lett; 2006 Aug; 404(1-2):107-11. PubMed ID: 16753260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
    Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1989 Jan; 248(1):127-34. PubMed ID: 2913267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
    Belozertseva IV; Andreev BV
    Eksp Klin Farmakol; 2000; 63(1):19-23. PubMed ID: 10763104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone-precipitated withdrawal in humans after acute morphine administration.
    Bickel WK; Stitzer ML; Wazlavek BE; Liebson IA
    NIDA Res Monogr; 1986; 67():349-54. PubMed ID: 3092089
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppressive effects of dichloromethane fraction from the Areca catechu nut on naloxone-precipitated morphine withdrawal in mice.
    Kumarnsit E; Keawpradub N; Vongvatcharanon U; Sawangjaroen K; Govitrapong P
    Fitoterapia; 2005 Sep; 76(6):534-9. PubMed ID: 15993008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of naloxone to antagonize large doses of opiates administered during nitrous oxide anesthesia.
    Heisterkamp DV; Cohen PJ
    Anesth Analg; 1974; 53(1):12-8. PubMed ID: 4855701
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic aspects of naloxone-precipitated morphine withdrawal in male and female prepubertal mice.
    Diaz SL; Hermida MP; Joannas LD; Olivera M; Ridolfi A; Villaamil EC; Balerio GN
    Biopharm Drug Dispos; 2007 Sep; 28(6):283-9. PubMed ID: 17570125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
    Cicero TJ; Aleem A; Meyer ER; Schmoeker PF; Miller BT
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1063-70. PubMed ID: 3528453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.